Advancing the Adoption of the DRC’s Essential Medicines List

In a three-day workshop jointly sponsored by the US Agency for International Development (USAID)-funded SIAPS and the World Health Organization (WHO), stakeholders adopted the essential medicines list (EML) for the Democratic Republic of Congo (DRC). The stakeholder consultation was carried out with the support of the DRC’s Ministry of Public Health and Pharmaceutical Directorate. Every … Read more

Video: Meet Chinwe Owunna

Reposted from Chinwe Owunna of Management Sciences for Health (MSH) describes the active surveillance approach used by the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program in Swaziland to increase understanding of medicines safety and risk/benefit context for TB and HIV patients. Watch video More about SIAPS

Information and Action to Address the Serious Threat of Antimicrobial Resistance

Malaika Ludman, SIAPS Technical Advisor; Claire Tindula, SIAPS Project Associate Does antimicrobial resistance mean the end of modern medicine as we know it? Not quite yet. However, in a report recently released on global surveillance of antimicrobial resistance (AMR), the World Health Organization (WHO) warned that “a post-antibiotic era – in which common infections and … Read more

Acting on the Call: Ending Preventable Maternal and Child Deaths through Pharmaceutical Systems Strengthening

Sheena Patel, Technical Advisor, and Kiley Workman, Project Associate Although the global community has had significant success in reducing maternal and child deaths in the past two decades, they continue to die of preventable causes at an alarming rate. This is especially pronounced for the most vulnerable and hard-to-reach populations. Universal access to maternal, newborn, … Read more